BIO names its vice chair and Amicus founder John Crowley as next CEO
Biotechnology Innovation Organization vice chair John Crowley will become the next CEO of the industry’s advocacy and lobbying organization on March 4, picking an insider from its board after searching for more than a year.
Crowley, who founded and led Amicus Therapeutics for 17 years as CEO and chair, will replace Rachel King, the DC-based group said Tuesday morning. King has been in the BIO post on an interim basis after the sudden departure of Michelle McMurry-Heath last October.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.